drugset / Trial / NCT02865915
MLE4901 vs. Placebo for the Treatment of PCOS
Phase 2
Terminated
55 enrolled
Millendo Therapeutics US, Inc.
Covance · collabMedpace, Inc. · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a Phase 2b double-blind, randomized, parallel-group, placebo-controlled study of MLE4901 versus placebo in women with PCOS.
Timeline
- Start
- 2016-07
- Primary completion
- 2017-09
- Completion
- 2017-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PAVINETANT | Small molecule | 40 mg | — |